论著

瑞巴派特在大鼠痛风性关节炎急性发作中的作用

  • 王贵红 ,
  • 左婷 ,
  • 李然 ,
  • 左正才
展开
  • 安徽医科大学附属安庆医院风湿免疫科,安徽安庆 246000

收稿日期: 2019-08-23

  网络出版日期: 2021-08-25

基金资助

安庆市医疗卫生科技计划项目(2018Z2003)

Effect of rebamipide on the acute gouty arthritis in rats induced by monosodium urate crystals

  • Gui-hong WANG ,
  • Ting ZUO ,
  • Ran LI ,
  • Zheng-cai ZUO
Expand
  • Department of Rheumatology and Immunology, Anqing Hospital of Anhui Medical University, Anqing 246000, Anhui, China

Received date: 2019-08-23

  Online published: 2021-08-25

Supported by

Anqing Medical Technology Project(2018Z2003)

摘要

目的: 了解瑞巴派特(rebamipide)在预防尿酸盐晶体诱导的大鼠痛风性关节炎急性发作中的作用。方法: 42只雄性大鼠按随机表法分为3组(n=14),以尿酸盐晶体制备大鼠急性痛风性踝关节炎模型,A组口服瑞巴派特治疗,B组口服秋水仙碱治疗,C组口服安慰剂治疗,观察各组踝关节的临床表现及病理变化,检测大鼠血清中白细胞介素(interleukin,IL)-1β、IL-6、IL-10、肿瘤坏死因子(tumor necrosis factor, TNF)-α水平。结果: C组大鼠关节炎的临床评分、肿胀指数在24 h达到最大值,后逐渐下降,72 h基本恢复正常。造模24 h后,C组的临床评分明显高于A组和B组[2 (1~3) vs.0 (0~1) vs.1 (0~2)],差异有统计学意义(P=0.008);C组的肿胀指数明显高于A组和B组[0.36 (0.16~0.52) vs. 0.11 (0~0.20) vs. 0.12 (0~0.16)],差异有统计学意义(P=0.005);组织学上,C组的滑膜组织中有大量中性粒细胞浸润[5分量表评分为4 (2~4)],A组[1 (0~2)]与B组[1 (0~2)]未见明显炎性细胞浸润,差异有统计学意义(P<0.001)。造模24 h后,C组大鼠血清中IL-1β、IL-6、IL-10和TNF-α水平明显高于A组和B组[IL-1β:(41.86±5.72) vs. (27.35±7.47) vs. (27.76±5.28) ng/L;IL-6:(1 575.55±167.11) vs. (963.53±90.22) vs. (964.08±99.31) ng/L;IL-10:(37.96±3.76) vs. (21.68±4.83) vs. (16.20±2.49) ng/L;TNF-α:(21.32±1.34) vs. (15.82±2.54) vs. (17.35±7.47) μg/L],差异均有统计学意义(P<0.001)。结论: 瑞巴派特在大鼠痛风模型中对痛风性关节炎急性发作起预防保护作用。

本文引用格式

王贵红 , 左婷 , 李然 , 左正才 . 瑞巴派特在大鼠痛风性关节炎急性发作中的作用[J]. 北京大学学报(医学版), 2021 , 53(4) : 716 -720 . DOI: 10.19723/j.issn.1671-167X.2021.04.016

Abstract

Objective: To investigate the role of rebamipide in the treatment of acute gout arthritis rats induced by monosodium urate (MSU) crystal. Methods: Forty-two male rats were randomly divided into three groups (n=14). Group A was treated with oral rebamipide, group B with oral colchicine, and group C with oral placebo. The rats were monitored for the induction of arthritis with clinical manifestations and pathological changes, and the levels of interleukin (IL)-1β、IL-6、IL-10, and tumor necrosis factor (TNF)-α in serum were measured. Results: In group C, the clinical score and swelling index reached the maximum in 24 h, and then gradually decreased to 72 h. After 24 h of model induced, the clinical scores in group C were significantly higher than those in group A and group B [2 (1-3) vs. 0 (0-1) vs. 1 (0-2), P<0.01], the swelling indexes in group C were significantly higher than those in group A and group B [0.36 (0.16-0.52) vs. 0.11 (0-0.20) vs. 0.12 (0-0.16), P<0.01]. Histologically, after 24 h of model induced, there was a large number of neutrophil infiltration in the synovium of group C [scale score: 4 (2-4)], and there was no significant inflammatory cell infiltration in group A [1 (0-2)] and group B [1 (0-2)], the difference was statistically significant (P<0.001). After 24 h of model induced, the levels of IL-1β, IL-6, IL-10, and TNF-α in serum of group C were significantly higher than those in group A and B [IL-1β: (41.86±5.72) vs. (27.35±7.47) vs. (27.76±5.28) ng/L, IL-6: (1 575.55±167.11) vs. (963.53±90.22) vs. (964.08±99.31) ng/L, IL-10: (37.96±3.76) vs. (21.68±4.83) vs. (16.20±2.49) ng/L, TNF-α: (21.32±1.34) vs. (15.82±2.54) vs. (17.35±7.47) μg/L, P<0.001]. Conclusion: Rebamipide has a protective effect on acute gout arthritis rats induced by MUS crystals.

参考文献

[1] 路杰, 崔凌凌, 李长贵, 等. 原发性痛风流行病学研究进展 [J]. 中华内科杂志, 2015, 54(3):244-247.
[2] 中华医学会风湿病学分会. 2016中国痛风诊疗指南 [J]. 中华内科杂志, 2016, 55(11):892-899.
[3] Kim SK, Choe JY, Park KY. Rebamipide suppresses monosodium urate crystal-induced interleukin-1β production through regulation of oxidative stress and Caspase-1 in THP-1 cells [J]. Inflammation, 2016, 39(1):473-482.
[4] Moon SJ, Woo YJ, Jeong JH, et al. Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes [J]. Osteoarthritis Cartilage, 2012, 20(11):1426-1438.
[5] Kohashi M, Ishimaru N, Arakaki R, et al. Effective treatment with oral administration of rebamipide in a mouse model of Sjögren’s syndrome [J]. Arthritis Rheum, 2008, 58(2):389-400.
[6] Coderre TJ, Wall PD. Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund’s adjuvant [J]. Pain, 1987, 28(3):379-393.
[7] Park JS, Oh Y, Park O, et al. PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells [J]. J Control Release, 2017, 267:163-171.
[8] Hartmann P, Szabó A, Eros G, et al. Anti-inflammatory effects of phosphatidylcholine in neutrophil leukocyte-dependent acute arthritis in rats [J]. Eur J Pharmacol, 2009, 622(1/3):58-64.
[9] Tramontini N, Huber C, Liu-Bryan R, et al. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis [J]. Arthritis Rheum, 2004, 50(8):2633-2639.
[10] Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation [J]. Immunol Rev, 2010, 233(1):218-232.
[11] Zhang Y, Zheng Y. Effects and mechanisms of potent caspase 1 inhibitor VX765 treatment on collagen-induced arthritis in mice [J]. Clin Exp Rheumatolm, 2016, 34(1):111-118.
[12] Jhang JJ, Lu CC, Yen GC. Epigallocatechin gallate inhibits urate crystals-induced peritoneal inflammation in C57BL/6 mice [J]. Mol Nutr Food Res, 2016, 60(10):2297-2303.
[13] Zhang S, Qing Q, Bai Y, et al. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: A systematic review and meta-analysis [J]. Dig Dis Sci, 2013, 58(7):1991-2000.
[14] Choe JY, Park KY, Lee SJ, et al. Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells [J]. Inflamm Res, 2010, 59(12):1019-1026.
[15] Kim H, Seo JY, Kim KH. Inhibition of lipid peroxidation, NFkappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells [J]. Dig Dis Sci, 2000, 45(3):621-628.
[16] Funahashi Y, Yoshida M, Yamamoto T, et al. Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model [J]. J Urol, 2014, 191(4):1147-1152.
[17] Suzuki Y, Hasegawa M, Matsui Y, et al. Intra-articular injection of rebamipide prevents articular cartilage degeneration in murine post-traumatic osteoarthritis models [J]. Mod Rheumatol, 2020, 30(4):765-772.
文章导航

/